통화 / ALVO
ALVO: Alvotech
8.41
USD
0.59
(6.56%)
ALVO 환율이 오늘 -6.56%로 변동했습니다. 당일 이 종목은 저가가 8.33이고 고가는 9.12이었습니다.
Alvotech 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALVO News
- Seeking Alpha Alvotech: A Fast Expanding Biosimilar Concern (NASDAQ:ALVO)
- Benzinga Why Is Alvotech Stock Trading Higher On Wednesday? - Alvotech (NASDAQ:ALVO)
- Investing Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair ® (omalizumab)
- Investing Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair ® (omalizumab)
- Investing European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea ® (aflibercept)
- Investing European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea ® (aflibercept)
- Investing Alvotech completes private placement with 40 institutional investors
- Investing Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami
- Investing Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
- Benzinga Why Is Dr Reddy's Stock Trading Higher On Thursday? - Dr Reddy's Laboratories (NYSE:RDY), Alvotech (NASDAQ:ALVO)
- Investing Talvotech at Jefferies Conference: Strategic Growth in Biosimilars
- Investing Dr. Reddy’s stock rises on biosimilar collaboration with Alvotech
- Investing Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda ® (pembrolizumab)
- Investing Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
- Investing Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
- Investing Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
- Benzinga Why Is Teva Stock Trading Higher On Tuesday? - Teva Pharmaceutical Indus (NYSE:TEVA)
- Investing UBS sees limited cost pass-through for US generic drug firms
- Investing Alvotech at BofA Securities Healthcare Conference: Strategic Biosimilar Focus
- Benzinga Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday - AppLovin (NASDAQ:APP), Alvotech (NASDAQ:ALVO)
- Investing Alvotech shares surge 6.6% as Q1 results top estimates
- Benzinga Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? - Alvotech (NASDAQ:ALVO), Teva Pharmaceutical Indus (NYSE:TEVA)
- Investing Teva and Alvotech stocks jump on FDA approval of SELARSDI
- Seeking Alpha Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade) (NASDAQ:ALVO)
일일 변동 비율
8.33
9.12
년간 변동
7.35
13.70
- 이전 종가
- 8.90
- 시가
- 9.00
- Bid
- 8.41
- Ask
- 8.71
- 저가
- 8.33
- 고가
- 9.12
- 볼륨
- 4.237 K
- 일일 변동
- -6.56%
- 월 변동
- -6.87%
- 6개월 변동
- -32.07%
- 년간 변동율
- -29.33%
15 7월, 화요일
11:00
ALL
- 활동
- 예측값
- 훑어보기
12:30
USD
- 활동
- 0.3%
- 예측값
- -0.3%
- 훑어보기
- 0.1%
12:30
USD
- 활동
- 0.2%
- 예측값
- 0.2%
- 훑어보기
- 0.1%
12:30
USD
- 활동
- 2.7%
- 예측값
- 2.4%
- 훑어보기
- 2.4%
12:30
USD
- 활동
- 2.9%
- 예측값
- 2.7%
- 훑어보기
- 2.8%
12:30
USD
- 활동
- 322.561
- 예측값
- 321.516
- 훑어보기
- 321.465
12:30
USD
- 활동
- 327.600
- 예측값
- 327.606
- 훑어보기
- 326.854
12:30
USD
- 활동
- -0.4%
- 예측값
- 0.1%
- 훑어보기
- 0.3%
12:30
USD
- 활동
- 0.3%
- 예측값
- 훑어보기
- 0.2%
12:30
USD
- 활동
- 0.3%
- 예측값
- 훑어보기
- 0.2%
12:30
USD
- 활동
- 321.500
- 예측값
- 320.395
- 훑어보기
- 320.580
12:30
USD
- 활동
- 328.364
- 예측값
- 훑어보기
- 327.509
12:30
USD
- 활동
- 5.5
- 예측값
- 2.2
- 훑어보기
- -16.0
13:15
USD
- 활동
- 예측값
- 훑어보기
15:00
USD
- 활동
- 0.3%
- 예측값
- 0.2%
- 훑어보기
- 0.2%
16:45
USD
- 활동
- 예측값
- 훑어보기